Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy

por Heske, Christine M.
Publicado 2020

Relapsed Rhabdomyosarcoma

por Heske, Christine M., Mascarenhas, Leo
Publicado 2021

The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma()

por Heske, Christine M., Yeung, Choh, Mendoza, Arnulfo, Baumgart, Joshua T., Edessa, Leah D., Wan, Xiaolin, Helman, Lee J.
Publicado 2016

Impact of race and ethnicity on presentation and outcomes of patients treated on rhabdomyosarcoma clinical trials: A report from the Children's Oncology Group

por Munnikhuysen, Senna R., Ekpo, Princess A., Xue, Wei, Gao, Zhengya, Lupo, Philip J., Venkatramani, Rajkumar, Heske, Christine M.
Publicado 2023

STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma

por Heske, Christine M., Mendoza, Arnulfo, Edessa, Leah D., Baumgart, Joshua T., Lee, Sunmin, Trepel, Jane, Proia, David A., Neckers, Len, Helman, Lee J.
Publicado 2016

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma

por Gibson, Anna E., Yeung, Choh, Issaq, Sameer H., Collins, Victor J., Gouzoulis, Michael, Zhang, Yiping, Ji, Jiuping, Mendoza, Arnulfo, Heske, Christine M.
Publicado 2020

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force

por Pacenta, Holly L., Allen-Rhoades, Wendy, Langenau, David, Houghton, Peter J., Keller, Charles, Heske, Christine M., Deel, Michael D., Linardic, Corinne M., Shern, Jack F., Stewart, Elizabeth, Turpin, Brian, Harrison, Douglas J., Khan, Javed, Mascarenhas, Leo, Skapek, Stephen X., Meyer, William H., Hawkins, Douglas S., Chen, Eleanor Y., Amatruda, James F., Hingorani, Pooja, Laetsch, Theodore W.
Publicado 2021